Literature DB >> 25986243

Male Breast Cancer: A Study in Small Steps.

Larissa A Korde1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25986243      PMCID： PMC4571790          DOI： 10.1634/theoncologist.2015-0174

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  15 in total

1.  Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.

Authors:  Dezheng Huo; Ruby T Senie; Mary Daly; Saundra S Buys; Shelly Cummings; Jacqueline Ogutha; Kisha Hope; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

2.  Male breast cancer in Cowden syndrome patients with germline PTEN mutations.

Authors:  J D Fackenthal; D J Marsh; A L Richardson; S A Cummings; C Eng; B G Robinson; O I Olopade
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

3.  Aromatase inhibitors in male breast cancer: a pooled analysis.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Hatem A Azim; Dimosthenis Chrysikos; Meletios-Athanassios Dimopoulos; Theodora Psaltopoulou
Journal:  Breast Cancer Res Treat       Date:  2015-04-08       Impact factor: 4.872

4.  Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

Authors:  Giovanna Masci; Michele Caruso; Francesco Caruso; Piermario Salvini; Carlo Carnaghi; Laura Giordano; Vittoria Miserocchi; Agnese Losurdo; Monica Zuradelli; Rosalba Torrisi; Luca Di Tommaso; Corrado Tinterri; Alberto Testori; Carlos A Garcia-Etienne; Wolfgang Gatzemeier; Armando Santoro
Journal:  Oncologist       Date:  2015-05-06

5.  BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.

Authors:  Zahi I Mitri; Michelle Jackson; Carolyn Garby; Juhee Song; Sharon H Giordano; Gabriel N Hortobágyi; Claire N Singletary; S Shahrukh Hashmi; Banu K Arun; Jennifer K Litton
Journal:  Oncologist       Date:  2015-05-06

6.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Authors:  Donald A Berry; Edwin S Iversen; Daniel F Gudbjartsson; Elaine H Hiller; Judy E Garber; Beth N Peshkin; Caryn Lerman; Patrice Watson; Henry T Lynch; Susan G Hilsenbeck; Wendy S Rubinstein; Kevin S Hughes; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

7.  Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Authors:  David M Euhus; Kristin C Smith; Linda Robinson; Amy Stucky; Olufunmilayo I Olopade; Shelly Cummings; Judy E Garber; Anu Chittenden; Gordon B Mills; Paula Rieger; Laura Esserman; Beth Crawford; Kevin S Hughes; Connie A Roche; Patricia A Ganz; Joyce Seldon; Carol J Fabian; Jennifer Klemp; Gail Tomlinson
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506

8.  Risk of subsequent cancer following breast cancer in men.

Authors:  Anssi Auvinen; Rochelle E Curtis; Elaine Ron
Journal:  J Natl Cancer Inst       Date:  2002-09-04       Impact factor: 13.506

9.  CHEK2 1100delC and male breast cancer in the Netherlands.

Authors:  Marijke Wasielewski; Michael A den Bakker; Ans van den Ouweland; Marion E Meijer-van Gelder; Henk Portengen; Jan G M Klijn; Hanne Meijers-Heijboer; John A Foekens; Mieke Schutte
Journal:  Breast Cancer Res Treat       Date:  2008-08-31       Impact factor: 4.872

10.  A retrospective analysis of survival and prognostic factors of male breast cancer from a single center.

Authors:  Amr A Soliman; Adel T Denewer; Wael El-Sadda; Ali H Abdel-Aty; Basel Refky
Journal:  BMC Cancer       Date:  2014-03-28       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.